Innovative Veterinary Diagnostic Setting A New Standard
PARATEST® by Bio-Techne Offers Simplicity, Stability, and Safety for Fecal Parasite Examinations
MINNEAPOLIS, March 1, 2017 /PRNewswire/ -- Bio-Techne Corporation has partnered with Brazil-based DK Diagnostics to release its first diagnostic tool for the veterinary market. The PARATEST system is an innovative parasitological system which contains the only non-toxic, biodegradable fixative available to the market. The PARATEST system will be manufactured at Bio-Techne's Diagnostic Division in Devens, MA site and leverages its state-of-art formulation, manufacturing, and packaging capabilities to bring this unique solution to companion animals and their owners.
The PARATEST system's patented self-contained, single-vial design coupled with up to 15-day morphology stability offers a safer, cleaner, cost effective, and more flexible alternative to existing fecal examination systems and products. In what is expected to become the new standard, this innovative system is uniquely eco-friendly, provides highly accurate results in less time than existing tests, and can be easily performed in the veterinarian's office without special equipment or training. The PARATEST system can test for a wide range of common parasites that companion animals can be infected by in all climates and geographies and helps ensure an accurate diagnosis to start the appropriate treatment quickly.
Dr. Andy Alhasssan, DMV, Ph.D. from Ipswich, MA commented, "PARATEST with ECO Greenfix® fixative is a major advance in parasite testing and diagnosis for companion animals. In addition to being highly effective, the system's self-contained format offers safety and non-toxic benefits for vets and technicians." Tova Bopp, RVT, Mt. Airy Animal Hospital in Mt. Airy, MD added "We love how simple and effective the PARATEST system is. Because of the 15-day morphology stability, samples can be prepped on a Friday and read on a Monday. When we need a quick result, the ability to prepare, read, and prescribe medication in 15 minutes is a real benefit to our clients."
Chuck Kummeth, President and Chief Executive Officer at Bio-Techne said, "We are excited to bring the PARATEST system to market in the US. This innovative product addresses several important limitations of current pet parasite testing techniques and will benefit pets and their owners alike. By leveraging our unique expertise in manufacturing, packaging, and biology we plan to bring more innovative solutions like this to more customers."
The PARATEST system has also been recognized as one of the Most Innovative Medical Devices according to the World Health Organization (WHO)'s First and Second Global Forum for Innovative Medical Devices (2010/2013) for its use in areas where human infection by parasites present a significant health risk.
Bio-Techne is featuring the PARATEST system in 2017 at all major veterinary conferences across North America (including NAVC, WVC, AAHA, and others).
ABOUT BIO-TECHNE CORPORATION:
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $499 million in net sales in fiscal 2016 and has approximately 1,650 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio-techne.com. For more information about PARATEST, please visit www.theparatest.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/innovative-veterinary-diagnostic-setting-a-new-standard-300415672.html
SOURCE Bio-Techne Corporation
Released March 1, 2017